LONDON /PRNewswire/ -- Advanced Sterilization Products (ASP) announced today a partnership with the Royal Liverpool University Hospital to strengthen their infection prevention efforts and promote better patient care by utilizing ASP's proven GLOSAIR(TM) area decontamination technology.
As part of a larger refurbishment project, Royal Liverpool University Hospital has appointed ASP to perform their deep clean decontamination service through the use of ASP GLOSAIR(TM) technology, supporting the ongoing measures undertaken by staff, cleaners and existing ASP infection prevention solutions used by the hospital. GLOSAIR(TM) Area Decontamination technology uses a low concentration hydrogen peroxide dry-mist technology which operates at room temperature to decontaminate a ward or patient room within three hours of operation time. Its proven efficacy[1] ensures that the safest possible environment is created for patients and healthcare professionals. For added convenience, the easy-to-operate ASP GLOSAIR(TM) area decontamination technology is also available for self-service usage by healthcare facilities. Healthcare professionals can decontaminate large and small spaces with ASP GLOSAIR(TM) technology as needed.
The first ward decontamination at the Royal Liverpool University Hospital has already been successfully completed and 14 additional ward decontaminations in multiple hospital sites are scheduled over the coming 10 months.

Ad Statistics
Times Displayed: 114615
Times Visited: 6802 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
The Royal Liverpool and Broadgreen University Hospitals NHS Trust has made significant advances in tackling Healthcare Associated Infections (HCAIs) to date and has been recognised as one of the winners in the inaugural NHS Liverpool Quality Awards for Innovation and Improvements.
Commenting on the hospital's infection control initiatives, Diane Wake, Director of Infection Prevention and Control at the Royal Liverpool University Hospital said: "Patients can be reassured that we are continuing to see significant falls in the number of C. Diff and MRSA cases. We have halved our C.Diff rates in the last year. With a greater emphasis on cleaning and cleaning standards, and the use of innovative solutions as provided by ASP, we have made tackling hospital infections our top priority. Our current performance clearly shows that our efforts are making a huge difference; we have gone from being one of the poorest to one of the best performing trusts in the country for infection control."